Effective with date of service July 15, 2021, Medicaid and NC Health Choice cover asparaginase erwinia chrysanthemi (recombinant)-rywn injection, for intramuscular use (Rylaze™)
To assist providers in navigating the managed care health plans' PCS referral and intake process, NC Medicaid has partnered with the health plans to implement a short-term solution for ACH providers who deliver PCS services.
The FDA has modified the Emergency Use Authorizations (EUAs) for Pfizer-BioNTech COVID-19 vaccine and Moderna COVID-19 vaccine to allow for administration of a third dose of an mRNA COVID-19 vaccine after an initial two-dose primary mRNA COVID-19 vaccine series for certain immunocompromised people.
Recommendations for Non-Emergency Medical Transportation (NEMT) Vendors and Drivers
The policy is extended through Nov. 30, 2021.
May be available for those at risk of not meeting financial obligations
Additional clarification about Nurse Practitioner credentialing requirements
Claims may be submitted to NCTracks for all IFSP services for dates of service starting on July 1, 2021.
Coverage season will begin Aug. 15, 2021
Not required for medications administered at the provider’s office or outpatient hospital clinic settings and billed as part of the professional claim (Physician Administered Drug Program).